Form 8-K - Current report:
SEC Accession No. 0001193125-25-065613
Filing Date
2025-03-27
Accepted
2025-03-27 17:10:24
Documents
14
Period of Report
2025-03-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d933210d8k.htm   iXBRL 8-K 27249
2 EX-10.1 d933210dex101.htm EX-10.1 69356
  Complete submission text file 0001193125-25-065613.txt   234717

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bntc-20250326.xsd EX-101.SCH 2887
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20250326_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20250326_pre.xml EX-101.PRE 10837
16 EXTRACTED XBRL INSTANCE DOCUMENT d933210d8k_htm.xml XML 3485
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 25780424
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)